As reported previously, phytoestrogen calycosin and ERβ agonist liquiritigenin could up-regulate ERβ expression and inhibit the activation of mTOR pathway in breast cancer cells and glioma cells, respectively [8, 9]. Here, MTOR is linked to breast carcinoma.